MEDIBANK PRIVATE LIMITED (MPL)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
![](/stocklogo/MPL.jpg)
MPL - MEDIBANK PRIVATE LIMITED
FNArena Sector :
Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS
FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Medibank Private is the largest Australian private health insurance provider. Previously an Australian Government business enterprise, established by the Whitlam government in 1975, it was privatised in 2014.
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$3.79
17 Jan |
OPEN $3.78 |
HIGH $3.81 |
7,268,586 LOW $3.77 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
OTHER COMPANIES IN THE SAME SECTOR | |||
AUB . CVW . FCL . GDG . HLI . IAG . NHF . NOL . QBE . SDF . SUN . TWR . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY23 Actual |
FY24 Actual |
FY25 Forecast |
FY26 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | 17.9 | 20.8 | xxx |
DPS (cps) | xxx | 16.6 | 17.8 | xxx |
EPS Growth | xxx | - 3.7% | 16.3% | xxx |
DPS Growth | xxx | 13.7% | 7.1% | xxx |
PE Ratio | xxx | N/A | 18.2 | xxx |
Dividend Yield | xxx | N/A | 4.7% | xxx |
Div Pay Ratio(%) | xxx | 92.8% | 85.5% | xxx |
Last ex-div: 04/09 - ex-div 9.4c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | 17.9 |
DPS All | xxx | xxx | xxx | xxx | xxx | 16.6 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 8,021.6 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 83.7 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 988.4 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 6.14 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 22.44 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 21.57 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | 10.85 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | 22.44 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 31.22 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 554.5 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 67 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 152 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 218 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 402 M |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 691 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 4.46 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 57.6 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 0.72 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | - |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 385 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | 3,060 M |
Capex
Capex % of Sales
Cost of Goods Sold
![](/images/chart-unavailable.png)
Selling, General & Admin. Exp & Other
Research & Development
![](/images/chart-unavailable.png)
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
EXTRA COVERAGE
Display All Commentary
No. Of Recommendations
Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.
MPL STOCK CHART
![](/wp-content/uploads/2020/10/img-side-banner-stock-analysis.jpg)
FNArena News on MPL
1 |
Rudi’s View: Best Buys & Convictions For 2025Jan 16 2025 - Rudi's View |
2 |
Rudi’s View: Final Best Buys & Conviction IdeasDec 23 2024 - Rudi's View |
3 |
Rudi’s View: Banks, WiseTech, Redox & Integral DiagnosticsDec 19 2024 - Rudi's View |
4 |
Next Week At A Glance -16-20 Dec 2024Dec 13 2024 - Weekly Reports |
5 |
Rudi’s View: Best Buys & Smaller Cap FavouritesDec 12 2024 - Rudi's View |
Latest Insurance News
1 |
ESG Focus: The Little Big Things – 21-11-2024Nov 21 2024 - ESG Focus |
2 |
New-Look Suncorp Ready To RumbleNov 14 2024 - Australia |
3 |
Steadfast’s Long MarchJul 02 2024 - Australia |
4 |
AUB Group Shares Poised For Break-OutJun 13 2024 - Technicals |
5 |
SMSFundamentals: Older People Are Life Insurers’ Future ChallengeOct 26 2023 - SMSFundamentals |
6 |
Australian Insurers And The WeatherOct 19 2023 - Feature Stories |
7 |
Steadfast Group’s US Entry Full Of PromiseOct 11 2023 - Australia |
8 |
Pros And Cons Of Insurance CompaniesAug 02 2023 - Australia |
9 |
Underlying Trends Positive For QBE InsuranceMay 15 2023 - Australia |
10 |
Rates Over Reinsurance For General InsurersFeb 01 2023 - Australia |